Search research articles
Contact Us
Filters
Showing results (21-30 of 38) with videos related to
Page
of 4
Sort By:
Digestive Diseases and Sciences
|
April 6, 2007
CARD15 status and familial predisposition for Crohn's disease and colonic gene expression
Claudio Csillag, Ole Haagen Nielsen, Rehannah Borup, et al.
World Journal of Gastroenterology
|
July 26, 2013
miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis
Mehmet Coskun, Jacob Tveiten Bjerrum, Jakob Benedict Seidelin, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
January 20, 2015
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals
Jacob Tveiten Bjerrum, Yulan Wang, Fuhua Hao, et al.
International Journal of Biological Sciences
|
March 28, 2022
Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets
Jacob Tveiten Bjerrum, Yulan Wang, Jingtao Zhang, et al.
Journal of Clinical Medicine
|
January 10, 2026
Transabdominal Intestinal Ultrasonography in Monitoring and Predicting Outcomes in Ulcerative Colitis-A Systematic Review
Sabrina Josefsen, Tobias Reinhold Larsen, Rune Wilkens, et al.
Journal of Crohn'S & Colitis
|
June 13, 2022
Early Intestinal Ultrasound Predicts Intravenous Corticosteroid Response in Hospitalised Patients With Severe Ulcerative Colitis
Johan F K F Ilvemark, Rune Wilkens, Peter Thielsen, et al.
BMC Medicine
|
October 17, 2017
Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease
Jacob Tveiten Bjerrum, Casper Steenholdt, Mark Ainsworth, et al.
Ugeskrift for Laeger
|
March 22, 2022
[Practical guide to the use of thiopurinesin patients with inflammatory bowel diseases]
Mirabella Zhao, Mads Damsgaard Wewer, Jacob Tveiten Bjerrum, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2022
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis
Emilie Kristine Dahl, Osama Karim Abed, Jens Kjeldsen, et al.
JCO Oncology Practice
|
October 14, 2025
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study
Emilie Kristine Dahl, Katrine Risager Christensen, Henrik Albæk Jacobsen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 38) with videos related to
Sort By:
Page
of 4
Digestive Diseases and Sciences
|
April 6, 2007
CARD15 status and familial predisposition for Crohn's disease and colonic gene expression
Claudio Csillag, Ole Haagen Nielsen, Rehannah Borup, et al.
World Journal of Gastroenterology
|
July 26, 2013
miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis
Mehmet Coskun, Jacob Tveiten Bjerrum, Jakob Benedict Seidelin, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
January 20, 2015
Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn's disease and healthy individuals
Jacob Tveiten Bjerrum, Yulan Wang, Fuhua Hao, et al.
International Journal of Biological Sciences
|
March 28, 2022
Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets
Jacob Tveiten Bjerrum, Yulan Wang, Jingtao Zhang, et al.
Journal of Clinical Medicine
|
January 10, 2026
Transabdominal Intestinal Ultrasonography in Monitoring and Predicting Outcomes in Ulcerative Colitis-A Systematic Review
Sabrina Josefsen, Tobias Reinhold Larsen, Rune Wilkens, et al.
Journal of Crohn'S & Colitis
|
June 13, 2022
Early Intestinal Ultrasound Predicts Intravenous Corticosteroid Response in Hospitalised Patients With Severe Ulcerative Colitis
Johan F K F Ilvemark, Rune Wilkens, Peter Thielsen, et al.
BMC Medicine
|
October 17, 2017
Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease
Jacob Tveiten Bjerrum, Casper Steenholdt, Mark Ainsworth, et al.
Ugeskrift for Laeger
|
March 22, 2022
[Practical guide to the use of thiopurinesin patients with inflammatory bowel diseases]
Mirabella Zhao, Mads Damsgaard Wewer, Jacob Tveiten Bjerrum, et al.
Alimentary Pharmacology & Therapeutics
|
September 19, 2022
Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis
Emilie Kristine Dahl, Osama Karim Abed, Jens Kjeldsen, et al.
JCO Oncology Practice
|
October 14, 2025
Risk of Colitis in Patients With Inflammatory Bowel Disease or Microscopic Colitis Exposed to Checkpoint Inhibitors: A National Danish Cohort Study
Emilie Kristine Dahl, Katrine Risager Christensen, Henrik Albæk Jacobsen, et al.
Page
of 4